These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 23525442

  • 21. 5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.
    Shi X, Ma Q, Huo Y, Su Y.
    Am J Physiol Cell Physiol; 2024 Oct 01; 327(4):C901-C912. PubMed ID: 39129491
    [Abstract] [Full Text] [Related]

  • 22. miR-223 reverses experimental pulmonary arterial hypertension.
    Meloche J, Le Guen M, Potus F, Vinck J, Ranchoux B, Johnson I, Antigny F, Tremblay E, Breuils-Bonnet S, Perros F, Provencher S, Bonnet S.
    Am J Physiol Cell Physiol; 2015 Sep 15; 309(6):C363-72. PubMed ID: 26084306
    [Abstract] [Full Text] [Related]

  • 23. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
    Wang L, Moonen JR, Cao A, Isobe S, Li CG, Tojais NF, Taylor S, Marciano DP, Chen PI, Gu M, Li D, Harper RL, El-Bizri N, Kim YM, Stankunas K, Rabinovitch M.
    Circ Res; 2023 Mar 03; 132(5):545-564. PubMed ID: 36744494
    [Abstract] [Full Text] [Related]

  • 24. Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH.
    Courboulin A, Barrier M, Perreault T, Bonnet P, Tremblay VL, Paulin R, Tremblay E, Lambert C, Jacob MH, Bonnet SN, Provencher S, Bonnet S.
    Eur Respir J; 2012 Sep 03; 40(3):618-29. PubMed ID: 22496325
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.
    Wang J, Chen Y, Lin C, Jia J, Tian L, Yang K, Zhao L, Lai N, Jiang Q, Sun Y, Zhong N, Ran P, Lu W.
    Am J Physiol Cell Physiol; 2014 Feb 15; 306(4):C364-73. PubMed ID: 24336649
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. LRP1 Deficiency in Vascular SMC Leads to Pulmonary Arterial Hypertension That Is Reversed by PPARγ Activation.
    Calvier L, Boucher P, Herz J, Hansmann G.
    Circ Res; 2019 Jun 07; 124(12):1778-1785. PubMed ID: 31023188
    [Abstract] [Full Text] [Related]

  • 32. Prostanoid EP4 agonist L-902,688 activates PPARγ and attenuates pulmonary arterial hypertension.
    Li HH, Hsu HH, Chang GJ, Chen IC, Ho WJ, Hsu PC, Chen WJ, Pang JS, Huang CC, Lai YJ.
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar 01; 314(3):L349-L359. PubMed ID: 29146573
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension.
    Grobs Y, Awada C, Lemay SE, Romanet C, Bourgeois A, Toro V, Nadeau V, Shimauchi K, Orcholski M, Breuils-Bonnet S, Tremblay E, Provencher S, Paulin R, Boucherat O, Bonnet S.
    Int J Mol Sci; 2021 Mar 13; 22(6):. PubMed ID: 33805714
    [Abstract] [Full Text] [Related]

  • 37. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
    Kong D, Liu J, Lu J, Zeng C, Chen H, Duan Z, Yu K, Zheng X, Zou P, Zhou L, Lv Y, Zeng Q, Lu L, Li J, He Y.
    Arterioscler Thromb Vasc Biol; 2024 Jun 13; 44(6):e172-e195. PubMed ID: 38572649
    [Abstract] [Full Text] [Related]

  • 38. Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.
    Wang Y, Dai S, Cheng X, Prado E, Yan L, Hu J, He Q, Lv Y, Lv Y, Du L.
    Nutr Metab Cardiovasc Dis; 2019 Jun 13; 29(6):639-651. PubMed ID: 30954415
    [Abstract] [Full Text] [Related]

  • 39. Inositol monophosphatase 1 as a novel interacting partner of RAGE in pulmonary hypertension.
    Rafikov R, McBride ML, Zemskova M, Kurdyukov S, McClain N, Niihori M, Langlais PR, Rafikova O.
    Am J Physiol Lung Cell Mol Physiol; 2019 Mar 01; 316(3):L428-L444. PubMed ID: 30604625
    [Abstract] [Full Text] [Related]

  • 40. Cathepsin S promotes the development of pulmonary arterial hypertension.
    Chang CJ, Hsu HC, Ho WJ, Chang GJ, Pang JS, Chen WJ, Huang CC, Lai YJ.
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul 01; 317(1):L1-L13. PubMed ID: 31017016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.